Scott Kang

Director, Antibody Discovery and Engineering @ Calico Life Sciences

About

I'm responsible for developing AI platforms to support drug discovery for age-related diseases. My focus is on leading a team that integrates graph neural networks, generative models, and multimodal biological data into scalable systems to prioritize targets and accelerate the development of drug candidates. Outside of work, I occasionally write, often listen, and enjoy learning through insightful conversations.

Country

City

United States

Industry

Automotive

Skill

Experience

Director, Antibody Discovery and Engineering

Calico Life Sciences

2020-7 - Present · 6 yrs 3 mos

In the early stages, I led the development of a drug-likeness prediction system based on graph neural networks, which achieved end-to-end standardized scoring of candidate molecules, provided target priority for the anti-aging pipeline, and helped the AI platform form a closed loop for research and development.

Sr. AI Scientist/Junior

Calico Life Sciences

2013-9 - 2020-7 · 6 yrs 11 mos

From junior to senior: As an early member, I participated in the establishment of the AI pharmaceutical platform, worked closely with biological research scientists, led the development of protein-small molecule interaction prediction and target discovery models, and promoted multiple candidate projects into the preclinical verification stage.